RxDoctor Payments Data

Robert Singh, MD

Vascular Surgery · Philadelphia, PANPI 1154447175

Payments from drug & device makers

$778in general payments, 2019–2025

Across 28 payments — averaging $27.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$387
  • Grifols USA, LLC$65
  • Takeda Pharmaceuticals U.S.A., Inc.$63
  • Johnson & Johnson$56
  • Biogen$50
  • Amgen$48
  • plus $109 from 5 others

What the payments were for

  • Food & beverage$778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$778 in reported general payments places this provider in the 15th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$16,206,925
Medicare patients
813
Services billed
753,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →